Markets

Corona Remedies IPO Day One: Check Subscription Status, GMP, And Financials

December 8, 2025

The initial public offering (IPO) of Corona Remedies Ltd opened for subscription on December 8, 2025, with a price band set between ₹1,008 and ₹1,062 per share. As of the morning of the first day, the IPO was subscribed 0.11 times, indicating a slow start. The IPO aims to raise ₹655.37 crore through the sale of 62 lakh shares, with listing expected on BSE and NSE on December 15.

Corona Remedies IPO Day One: Check Subscription Status, GMP, And Financials

Credit: Feedburner

Key Highlights

Corona Remedies IPO opened for subscription on December 8, 2025.
The IPO is priced between ₹1,008 and ₹1,062 per share.
It aims to raise ₹655.37 crore through the offer of 62 lakh shares.
As of the opening day, the IPO was subscribed 0.11 times.
Listing on stock exchanges BSE and NSE is expected on December 15.

IPOs

Sources

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

Corona Remedies IPO Day One: Check Subscription Status, GMP, And Financials

Key Highlights

Sources

Related Stories

6 stocks and ETFs that these unsung market heroes see outperforming in 2026

Stock Market Today: Dow Falls On Powell Probe; Abercrombie Plunges On Outlook (Live Coverage)

Wall Street opens lower on renewed concerns over Fed’s independence, financial stocks dip